Abstract：Transurethral resection of bladder tumor (TURBT) is the principle method for treating non-muscle invasive bladder cancer. Traditional TURBT has a penal of intrinsic shortcomings such as piecemeal resection, difficulty for precise pathologic staging, and oburator reflex. In recent years, with the development of modern technologies, TURBT has achieved rapid progresses in en bloc resection and morbidity reduction, as reviewed in this article.
[1]Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin, 2014,64(1):9-29. [2]Babjuk M, Oosterlinck W, Sylvester R, et al. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol, 2011,59(6):997-1008. [3]Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol, 2006,49(3):466-477. [4]Brausi M, Collette L, Kurth K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol, 2002,41(5):523-531. [5]Stenzl A, Burger M, Fradet Y, et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol, 2010,184(5):1907-1913. [6]Grossman HB, Stenzl A, Fradet Y, et al. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol, 2012,188(1):58-62. [7]Burger M, Grossman HB, Droller M, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol, 2013,64(5):846-854. [8]Schumacher MC, Holmng S, Davidsson T, et al. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic acid under visible and fluorescent light: results of a prospective, randomised, multicentre study. Eur Urol, 2010,57(2):293-299. [9]Richards KA, Smith ND, Steinberg GD. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. J Urol, 2014,191(6):1655-1664. [10]Herr HH. Narrow band imaging cystoscopy. Urol Oncol, 2011,29(4):353-357. [11]Li K, Lin T, Fan X, et al. Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Int J Urol, 2013,20(6):602-609. [12]Geavlete B, Multescu R, Georgescu D, et al. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors: results of a prospective, randomized comparison to the standard approach. Urology, 2012,79(4):846-851. [13]Brausi M, Witjes JA, Lamm D, et al. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the international bladder cancer group. J Urol, 2011,186(6):2158-2167. [14]Burger M, Oosterlinck W, Konety B, et al. ICUD-EAU international consultation on bladder cancer 2012: non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol, 2013,63(1):36-44. [15]National comprehensive cancer network clinical practice guidelines in oncology (NCCN Guidelines). Bladder Cancer, Version 1.2013. Available at www.nccn.org. Accessed July 3, 2013. [16]Dutta SC, Smith JA, Shappell SB, et al. Clinical understaging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol, 2001,166(2):490-493. [17]Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol, 1999,162(1):74-76. [18]Adiyat KT, Katkoori D, Soloway CT, et al. "Complete transurethral resection of bladder tumor": are the guidelines being followed? Urology, 2010,75(2):365-367.[19]Herr HW. Role of re-resection in non-muscle-invasive bladder cancer. Sci World J, 2011,11:283-288. [20]Divrik RT, Sahin AF, Yildirim U, et al. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomized clinical trial. Eur Urol, 2010,58(2):185-190. [21]Divrik RT, Yildirim U, Zorlu F, et al. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumours of the bladder who received intravesical mitomycin: a prospective, randomised clinical trial. J Urol, 2006,175(5):1641-1644. [22]Herr HW. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol, 2005,174(6):2134-2137. [23]Kawada T, Ebihara K, Suzuki T, et al. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol, 1997,157(6):2225-2226. [24]Ukai R, Kawashita E, Ikeda H. A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol, 2000,163(3):878-879. [25]Saito S. Transurethral en bloc resection of bladder tumours. J Urol, 2001,166:2148-2150. [26]Wolters M, Kramer MW, Becker JU, et al. Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol, 2011,29:429-432. [27]Muto G, Collura D, Giacobbe A, et al. Thulium:yttrium-aluminumegarnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages. Urology, 2014,83(4):851-855. [28]Naselli A, Introini C, Germinale F, et al. En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int, 2012,109 (6):960-963. [29]Hollenbeck BK, Taub DA, Dunn RL, et al. Quality of care: partial cystectomy for bladder cancer--a case of inappropriate use? J Urol, 2005,174(3):1050-1054. [30]Kassouf W, Swanson D, Kamat AM, et al. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M.D. Anderson Cancer Center experience. J Urol, 2006,175(6):2058-2062. [31]Holzbeierlein JM, Lopez-Corona E, Bochner BH, et al. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. J Urol, 2004, 172(3):878-881. [32]Yang Y, Wei ZT, Zhang X, et al. Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. J Urol, 2009,182(1):66-69. [33]宋伟宁,徐阿祥,孙圣坤,等.经尿道针状电极膀胱部分切除术治疗膀胱癌的初步经验.微创泌尿外科杂志, 2014,3(2):108-111. [34]Neulander EZ, Katz T, Klein J, et al. Re: Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. J Urol, 2010,183(3):1257. [35]Zhu Y, Jiang X, Zhang J, et al. Safety and ef cacy of holmium laser resection for primary nonmuscle invasive bladder cancer versus transurethral electroresection: single-center experience. Urology, 2008,72(3):608-612. [36]Xishuang S, Deyong Y, Xiangyu C, et al. Comparing the safety and ef ciency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol, 2010,24(1):69-73. [37]Tao W, Yang D, Shan Y, et al. Safety and efficacy of 120W high performance system green light laser vaporization for non-muscle-invasive bladder cancer. J Xray Sci Technol, 2013,21(2):309-316. [38]Pantuck AJ, Baniel J, Kirkali Z, et al. A novel resectoscope for transurethral resection of bladder tulnours and the prostate. J Urol, 2007, 178(6):2331-2336. [39]Canter DJ, Ogan K, Master VA. Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors. Can J Urol, 2012,19(2):6211-6216. [40]Rodríguez JG, Monzón AJ, Alvarez RCG, et al. An alternative technique to prevent of obturator nerve stimulation during lateral bladder tumors transurethral resection. Actas Urol Esp, 2005,29(5):445-447. [41]孙圣坤,宋兵,宋勇,等.超声引导闭孔神经阻滞在膀胱肿瘤电切中的应用.微创泌尿外科杂志, 2013, 2(1):76-78. [42]Pladzyk K, Jureczko L, Lazowski T. Over 500 obturator nerve blocks in the lithotomy position during transurethral resection of bladder tumor. Cent European J Urol, 2012,65(2):67-70. [43]Jo YY, Choi E, Kil HK. Comparison of the success rate of inguinal approach with classical pubic approach for obturator nerve block in patients undergoing TURB. Korean J Anesthesiol, 2011,61(2):143-147. [44]Puppo P, Bertolotto F, Introini C, et al. Bipolar transurethral resection in saline (TURis): outcome and complication rates after the first 1000 cases. J Endourol, 2009,23(7):1145-1149. [45]Gupta NP, Saini AK, Dogra PN, et al. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience. BJU Int, 2011,108(4):553-556. [46]Venkatramani V, Panda A, Manojkumar R, et al. Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled Trial. J Urol, 2014,191(6):1703-1707.
